HYBRID EVENT: You can participate in person at Tokyo, Japan from your home or work.
Speaker at International Cancer Conference 2026 - Jose Manuel Cervera Grau
Keynote Presentation
Jose Manuel Cervera Grau, Preclinical Lab and Computational Drug Discovery Program, Relayer Biotech Inc, Spain

Will be Updated Soon...

Speaker at International Cancer Conference 2026 - Shinya Tajima
Keynote Presentation
Shinya Tajima, National Hospital Organization, Shizuoka Medical Centre, Japan

We would like to present a only case study: However, our important findings might lead to help the interpretations of “tumour microenvironment (TME)”. We herein presenting about 70-year-old female. She presented with a palpable mass in the upper inner quadrant of t [....] » Read More

Speaker at International Cancer Conference 2026 - Mercy Osoro
Oral Presentation (In-Person)
Mercy Osoro, National Cancer Institute of Kenya, Kenya

Background: With rising cancer incidence and expanding access to treatment, the population of cancer survivors is increasing. However, survivorship and long-term care remain fragmented, with many patients lacking structured follow-up, psychosocial support, and management of late [....] » Read More

Speaker at International Cancer Conference 2026 - Mariam Ally Uledi
Oral Presentation (In-Person)
Mariam Ally Uledi, Bugando Medical Centre, Tanzania, United Republic of

Background: Globally, there is an increase in breast cancer (BC) diagnoses before the age of 40 years were these individuals are in their reproductive age. One of the most significant side effects of chemotherapy for premenopausal women with BC is Chemotherapy-induced Amenorrhea [....] » Read More

Speaker at International Cancer Conference 2026 - Nermeen Mohamed Elbakary
Oral Presentation (In-Person)
Nermeen Mohamed Elbakary, Egyptian Atomic Energy Authority, Egypt

Tumor resistance is typically blamed for the failure of radiotherapy and chemotherapy to treat cancer in clinic patients. To improve the cytotoxicity of tumor cells using radiation in conjunction with specific tumor-selective cytotoxic drugs is crucial. Pomegranate has received o [....] » Read More

Speaker at International Cancer Conference 2026 - K R Muralidhar
Oral Presentation (In-Person)
K R Muralidhar, Karkinos Healthcare, India

Introduction and Objective: Radiation therapy plays a central role in cancer management; however, its success is often limited by tumour radio resistance and the risk of late treatment-related toxicities, even with advanced technologies and across various forms of radiation and i [....] » Read More

Speaker at International Cancer Conference 2026 - Yunjian
Oral Presentation (In-Person)
Yunjian, Sun Yat Sen University First Affiliated Hospital, China

Background: Over the past decade, Robotic and laparoscopic techniques in nipple-sparing mastectomy (NSM), have gained prominence in the field of breast surgery. However, the complexity of these procedures necessitates systematic training programs to ensure surgical competency. Th [....] » Read More

Speaker at International Cancer Conference 2026 - Abhishek Swarnakar
Poster Presentation (In-Person)
Abhishek Swarnakar, CSIR Indian Institute of Chemical Biology, India

Tumor-infiltrating lymphocytes (TILs) strongly influence clinical outcomes in many solid cancers, yet ovarian tumors frequently retain an immunologically “cold” phenotype that prevents effective immune entry and sustains immune evasion. Although oncolytic adenoviruses [....] » Read More

Speaker at International Cancer Conference 2026 - Rajvir Dahiya
Keynote Presentation (Virtual)
Rajvir Dahiya, University of California San Francisco, United States

Current screening methods—radiological imaging, DNA-based tests, and pathological assessments—often fail to detect malignancies at early stages. Despite technological advances, gene-based diagnostics specifically designed for early cancer detection remain limited. To [....] » Read More

Speaker at International Cancer Conference 2026 - George Zachos
Keynote Presentation (Virtual)
George Zachos, University of Crete, Greece

Chromatin bridges are strings of mis-segregated chromatin connecting the anaphase poles or daughter nuclei in mitotic cell division and can arise from incomplete DNA replication or decatenation, or from dicentric chromosomes generated by end-to-end chromosome fusions. Chromatin b [....] » Read More

Speaker at International Cancer Conference 2026 - Patricia Tai
Keynote Presentation (Virtual)
Patricia Tai, UpToDate, Canada

Will be Updated Soon...

Speaker at International Cancer Conference 2026 - Omar Mohammad Alqaisi
Oral Presentation (Virtual)
Omar Mohammad Alqaisi, Al-Zaytoonah University, Jordan

Selenium deficiency is associated with impaired immunity and leukemogenesis. Selenium compounds exhibit antiproliferative and proapoptotic effects in leukemic models, indicating therapeutic potential. However, no comprehensive review has assessed selenium’s impact on leukem [....] » Read More

Speaker at International Cancer Conference 2026 - Omar Mohammad Alqaisi
Oral Presentation (Virtual)
Omar Mohammad Alqaisi, Al-Zaytoonah University, Jordan

Sexual health is a fundamental component of quality of life that is frequently compromised in cancer patients. In melanoma care, these issues remain under addressed despite increasing survivorship. This scoping review aimed to map the current literature on sexual health concerns [....] » Read More

Speaker at International Cancer Conference 2026 - Eleni Petsalaki
Oral Presentation (Virtual)
Eleni Petsalaki, University of Crete, Greece

Chromatin bridges are strands of incompletely segregated DNA connecting the anaphase poles or daughter nuclei. Chromatin bridges can arise from incompletely replicated DNA, defective resolution of DNA catenates or dicentric chromosomes which are formed by chromosome fusions. If u [....] » Read More

Speaker at International Cancer Conference 2026 - Ratan Kumar Sarkar
Oral Presentation (Virtual)
Ratan Kumar Sarkar, Independent Researcher, India

The cancer drugs(SBDD) generally blocks cell signaling but it also blocks disintegration of lunar gravity(705) and electronic time(27 or 27*0.0019 = 0.0513 or 513) that would not co-exists driving to protein synthesis until neutralization of 27 e.g. 609(AFP) + 291 = 900 where 609 [....] » Read More

Speaker at International Cancer Conference 2026 - Saumya Pandey
Oral Presentation (Virtual)
Saumya Pandey, IndiraIVF Hospital, India

Objectives: Inflammation is a hallmark of HPV-mediated cervical cancer; Matrix metalloproteinase [MMP]-2 and tissue inhibitor of metalloproteinase [TIMP]-2 are emerging as pivotal players in inflammation and carcinogenesis. My study aimed to evaluate the role of MMP-2 (-735C>T [....] » Read More

Speaker at International Cancer Conference 2026 - Widia Rosita
Poster Presentation (Virtual)
Widia Rosita, Dr. Sardjito General Hospital, Indonesia

Sinonasal squamous cell carcinoma (SNSCC) is a rare head and neck malignancy that often presents at an advanced stage because initial symptoms mimic benign inflammatory disease. In high tuberculosis (TB) burden countries such as Indonesia, therapeutic decision-making may be furth [....] » Read More

Will be updated soon...!
Youtube
Watsapp